These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 28680034)
1. High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis. Santos JRA; Ribeiro NQ; Bastos RW; Holanda RA; Silva LC; Queiroz ER; Santos DA Sci Rep; 2017 Jul; 7(1):4661. PubMed ID: 28680034 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine, against Cryptococcus gattii: an emerging fungal pathogen. Nishikawa H; Fukuda Y; Mitsuyama J; Tashiro M; Tanaka A; Takazono T; Saijo T; Yamamoto K; Nakamura S; Imamura Y; Miyazaki T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Kohno S; Izumikawa K J Antimicrob Chemother; 2017 Jun; 72(6):1709-1713. PubMed ID: 28201509 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics/pharmacodynamic correlations of fluconazole in murine model of cryptococcosis. Santos JR; César IC; Costa MC; Ribeiro NQ; Holanda RA; Ramos LH; Freitas GJ; Paixão TA; Pianetti GA; Santos DA Eur J Pharm Sci; 2016 Sep; 92():235-43. PubMed ID: 27235581 [TBL] [Abstract][Full Text] [Related]
4. Pioglitazone as an adjuvant of amphotericin B for the treatment of cryptococcosis. Ribeiro NQ; Santos APN; Emídio ECP; Costa MC; Freitas GJC; Carmo PHF; Silva MF; de Brito CB; de Souza DG; Paixão TA; Santos DA Int J Antimicrob Agents; 2019 Sep; 54(3):301-308. PubMed ID: 31279153 [TBL] [Abstract][Full Text] [Related]
5. Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592 [TBL] [Abstract][Full Text] [Related]
6. A subdose of fluconazole alters the virulence of Cryptococcus gattii during murine cryptococcosis and modulates type I interferon expression. Fontes AC; Bretas Oliveira D; Santos JR; Carneiro HC; Ribeiro NQ; Oliveira LV; Barcellos VA; Paixão TA; Abrahão JS; Resende-Stoianoff MA; Vainstein MH; Santos DA Med Mycol; 2017 Feb; 55(2):203-212. PubMed ID: 27486215 [TBL] [Abstract][Full Text] [Related]
7. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis. Magalhães TFF; Costa MC; Holanda RA; Ferreira GF; Carvalho VSD; Freitas GJC; Ribeiro NQ; Emídio ECP; Carmo PHF; de Brito CB; de Souza DG; Rocha CEV; Paixão TA; de Resende-Stoianoff MA; Santos DA Med Mycol; 2020 Aug; 58(6):835-844. PubMed ID: 31919505 [TBL] [Abstract][Full Text] [Related]
8. Additive potential of combination therapy against cryptococcosis employing a novel amphotericin B and fluconazole loaded dual delivery system. Khan AA; Alanazi AM; Jabeen M; Khan S; Malik A Eur J Pharm Sci; 2018 Jul; 119():171-178. PubMed ID: 29653177 [TBL] [Abstract][Full Text] [Related]
9. Curcumin enhances the activity of fluconazole against Cryptococcus gattii-induced cryptococcosis infection in mice. da Silva DL; Magalhães TF; Dos Santos JR; de Paula TP; Modolo LV; de Fátima A; Buzanello Martins CV; Santos DA; de Resende-Stoianoff MA J Appl Microbiol; 2016 Jan; 120(1):41-8. PubMed ID: 26442997 [TBL] [Abstract][Full Text] [Related]
10. Atorvastatin as a promising anticryptococcal agent. Ribeiro NQ; Costa MC; Magalhães TFF; Carneiro HCS; Oliveira LV; Fontes ACL; Santos JRA; Ferreira GF; Araujo GRS; Alves V; Frases S; Paixão TA; de Resende Stoianoff MA; Santos DA Int J Antimicrob Agents; 2017 Jun; 49(6):695-702. PubMed ID: 28450174 [TBL] [Abstract][Full Text] [Related]
11. Correlation of the in vitro antifungal drug susceptibility with the in vivo activity of fluconazole in a murine model of cerebral infection caused by Cryptococcus gattii. Mendes FE; Oliveira LV; Faria ES; Alvarenga DG; Pinto MR; Taborda CP; Soares BM; Cisalpino PS; Santos DA Eur J Clin Microbiol Infect Dis; 2010 Dec; 29(12):1525-32. PubMed ID: 20803047 [TBL] [Abstract][Full Text] [Related]
12. Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis. Freitas GJC; Ribeiro NQ; Gouveia-Eufrasio L; Emidio ECP; Guimarães GM; César IC; Paixão TA; Oliveira JBS; Caza M; Kronstad JW; Santos DA Int J Antimicrob Agents; 2023 Jul; 62(1):106807. PubMed ID: 37030471 [TBL] [Abstract][Full Text] [Related]
13. Dynamic interaction between fluconazole and amphotericin B against Cryptococcus gattii. Santos JR; Gouveia LF; Taylor EL; Resende-Stoianoff MA; Pianetti GA; César IC; Santos DA Antimicrob Agents Chemother; 2012 May; 56(5):2553-8. PubMed ID: 22290956 [TBL] [Abstract][Full Text] [Related]
14. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID). Silva EG; Paula CR; de Assis Baroni F; Gambale W Mycopathologia; 2012 Jun; 173(5-6):445-9. PubMed ID: 22071662 [TBL] [Abstract][Full Text] [Related]
15. Fluphenazine antagonizes with fluconazole but synergizes with amphotericin B in the treatment of candidiasis. Lu Y; Zhou Z; Mo L; Guo Q; Peng X; Hu T; Zhou X; Ren B; Xu X Appl Microbiol Biotechnol; 2019 Aug; 103(16):6701-6709. PubMed ID: 31201451 [TBL] [Abstract][Full Text] [Related]
16. Treatment with pCramoll Alone and in Combination with Fluconazole Provides Therapeutic Benefits in Jandú JJ; Costa MC; Santos JRA; Andrade FM; Magalhães TF; Silva MV; Castro MCAB; Coelho LCBB; Gomes AG; Paixão TA; Santos DA; Correia MTS Front Cell Infect Microbiol; 2017; 7():211. PubMed ID: 28596945 [No Abstract] [Full Text] [Related]
17. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans. Silva EG; Paula CR; Dias AL; Chang MR; Ruiz Lda S; Gambale V; Prates RA; Ribeiro MS Mycopathologia; 2011 Apr; 171(4):261-6. PubMed ID: 20972836 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis. de Castro Spadari C; da Silva de Bastiani FWM; Pisani PBB; de Azevedo Melo AS; Ishida K Arch Microbiol; 2020 May; 202(4):773-784. PubMed ID: 31832690 [TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of pedalitin and amphotericin B against Cryptococcus neoformans by in vitro and in vivo evaluation. Sangalli-Leite F; Scorzoni L; Alves de Paula E Silva AC; da Silva JF; de Oliveira HC; de Lacorte Singulani J; Gullo FP; Moraes da Silva R; Regasini LO; Siqueira da Silva DH; da Silva Bolzani V; Fusco-Almeida AM; Soares Mendes-Giannini MJ Int J Antimicrob Agents; 2016 Nov; 48(5):504-511. PubMed ID: 27742203 [TBL] [Abstract][Full Text] [Related]